MichaelRaymondBurgessMDPhD
Oncology • San Francisco, CAHematologic Oncology
Executive Director, Translational Medicine at Celgene
Dr. Burgess is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
995 Potrero Ave
Building 80, Ward 86
San Francisco, CA 94110Phone+1 415-839-7127Fax+1 415-839-7018- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2009 - 2013- University of California (San Francisco)Residency, Internal Medicine, 2007 - 2009
David Geffen School of Medicine at UCLAClass of 2007
University of California, Los AngelesPh.D., Molecular Biology, 2000 - 2005
Certifications & Licensure
CA State Medical License 2008 - 2024- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers Start of enrollment: 2015 Mar 12
- A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS) Start of enrollment: 2016 Mar 01
- Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma Start of enrollment: 2018 Apr 03
- Join now to see all
Publications & Presentations
PubMed
- 32 citationsGene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS.Ningfei An, Saira Khan, Sandeep Gurbuxani, Stephanie N. Konecki, Michael R. Burgess, Megan E. McNerney, Molly K. Imgruet> ;Blood. 2018 Jun 14
- 118 citationsKRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.Michael R. Burgess, Eugene Hwang, Rana Mroue, Craig M. Bielski, Anica M. Wandler, Benjamin J. Huang, Ari J. Firestone, Amy Young, Jennifer A. Lacap, Lisa Crocker, Saur...> ;Cell. 2017 Feb 23
- 69 citationsThe creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia.Nina Fenouille, Christopher F. Bassil, Issam Ben-Sahra, Lina Benajiba, Gabriela Alexe, Azucena Ramos, Yana Pikman, Amy Saur Conway, Michael R. Burgess, Qing Li, Freder...> ;Nature Medicine. 2017 Mar 1
- Join now to see all
Press Mentions
Danette Mitchell: The Road to a Cure for Sickle Cell DiseaseDecember 9th, 2021- Amazon Launches Health Centers to Boost Employee Access to CareJuly 15th, 2020
Whistleblower Dr. Rick Bright Warns 'Window Is Closing' to Address Coronavirus in Congressional TestimonyMay 14th, 2020
Grant Support
- Postdoctoral FellowshipAmerican Cancer Society2014–2015
Professional Memberships
- Member
- Member
- Member
- Member
Hospital Affiliations
Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
